In this study, we analyzed TIMP1 expression in tumor epithelial and stromal cells, as well as TIMP1 serum levels, in a cohort of 776 CRC patients (606 with preoperative serum TIMP1 data and 757 with tissue TIMP1 data). Here, TIMP1 is linked to colorectal carcinoma.